Literature DB >> 27081073

Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.

Kaitlyn Sadtler1, Kenneth Estrellas1, Brian W Allen1, Matthew T Wolf1, Hongni Fan2, Ada J Tam2, Chirag H Patel2, Brandon S Luber3, Hao Wang3, Kathryn R Wagner4, Jonathan D Powell2, Franck Housseau2, Drew M Pardoll2, Jennifer H Elisseeff1.   

Abstract

Immune-mediated tissue regeneration driven by a biomaterial scaffold is emerging as an innovative regenerative strategy to repair damaged tissues. We investigated how biomaterial scaffolds shape the immune microenvironment in traumatic muscle wounds to improve tissue regeneration. The scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper 2 pathway that guides interleukin-4-dependent macrophage polarization, which is critical for functional muscle recovery. Manipulating the adaptive immune system using biomaterials engineering may support the development of therapies that promote both systemic and local pro-regenerative immune responses, ultimately stimulating tissue repair.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27081073      PMCID: PMC4866509          DOI: 10.1126/science.aad9272

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ.

Authors:  Omar A Ali; Prakriti Tayalia; Dmitry Shvartsman; Sarah Lewin; David J Mooney
Journal:  Adv Funct Mater       Date:  2013-08-01       Impact factor: 18.808

2.  Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Authors:  A J Allman; T B McPherson; S F Badylak; L C Merrill; B Kallakury; C Sheehan; R H Raeder; D W Metzger
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

Review 3.  Innate and adaptive immune response to apoptotic cells.

Authors:  Yufeng Peng; David A Martin; Justin Kenkel; Kang Zhang; Carol Anne Ogden; Keith B Elkon
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

4.  The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens.

Authors:  Amy J Allman; Timothy B McPherson; Lisa C Merrill; Stephen F Badylak; Dennis W Metzger
Journal:  Tissue Eng       Date:  2002-02

5.  Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants.

Authors:  Omar A Ali; Catia Verbeke; Chris Johnson; R Warren Sands; Sarah A Lewin; Des White; Edward Doherty; Glenn Dranoff; David J Mooney
Journal:  Cancer Res       Date:  2014-01-30       Impact factor: 12.701

6.  Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect.

Authors:  Vincent J Mase; Joseph R Hsu; Steven E Wolf; Joseph C Wenke; David G Baer; Johnny Owens; Stephen F Badylak; Thomas J Walters
Journal:  Orthopedics       Date:  2010-07-13       Impact factor: 1.390

Review 7.  IGF-1, inflammation and stem cells: interactions during muscle regeneration.

Authors:  Foteini Mourkioti; Nadia Rosenthal
Journal:  Trends Immunol       Date:  2005-10       Impact factor: 16.687

8.  Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration.

Authors:  Jose E Heredia; Lata Mukundan; Francis M Chen; Alisa A Mueller; Rahul C Deo; Richard M Locksley; Thomas A Rando; Ajay Chawla
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

9.  Changes in CEBPB expression in circulating leukocytes following eccentric elbow-flexion exercise.

Authors:  Jamie Blackwell; Lorna W Harries; Luke C Pilling; Luigi Ferrucci; Andrew Jones; David Melzer
Journal:  J Physiol Sci       Date:  2014-11-13       Impact factor: 2.781

10.  Pro-inflammatory mediation of myoblast proliferation.

Authors:  Jeffrey S Otis; Sarah Niccoli; Nicole Hawdon; Jessica L Sarvas; Melinda A Frye; Adam J Chicco; Simon J Lees
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more
  144 in total

Review 1.  Rejuvenating Strategies for Stem Cell-Based Therapies in Aging.

Authors:  Joana Neves; Pedro Sousa-Victor; Heinrich Jasper
Journal:  Cell Stem Cell       Date:  2017-02-02       Impact factor: 24.633

Review 2.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

3.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2017-07-21       Impact factor: 5.414

Review 4.  Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials<sup/>.

Authors:  Jenna L Dziki; Luai Huleihel; Michelle E Scarritt; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-05-19       Impact factor: 3.845

5.  Matrix-Bound Nanovesicles Recapitulate Extracellular Matrix Effects on Macrophage Phenotype.

Authors:  Luai Huleihel; Joseph G Bartolacci; Jenna L Dziki; Tatiana Vorobyov; Brooke Arnold; Michelle E Scarritt; Catalina Pineda Molina; Samuel T LoPresti; Bryan N Brown; Juan Diego Naranjo; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-06-30       Impact factor: 3.845

Review 6.  Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.

Authors:  Bryan N Brown; Martin J Haschak; Samuel T Lopresti; Elizabeth C Stahl
Journal:  Semin Immunol       Date:  2017-05-20       Impact factor: 11.130

Review 7.  Macrophage-based therapeutic strategies in regenerative medicine.

Authors:  Kara L Spiller; Timothy J Koh
Journal:  Adv Drug Deliv Rev       Date:  2017-05-16       Impact factor: 15.470

8.  Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.

Authors:  Kenneth M Estrellas; Liam Chung; Lindsay A Cheu; Kaitlyn Sadtler; Shoumyo Majumdar; Jyothi Mula; Matthew T Wolf; Jennifer H Elisseeff; Kathryn R Wagner
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

9.  Determination of a Critical Size Threshold for Volumetric Muscle Loss in the Mouse Quadriceps.

Authors:  Shannon E Anderson; Woojin M Han; Vunya Srinivasa; Mahir Mohiuddin; Marissa A Ruehle; June Young Moon; Eunjung Shin; Cheryl L San Emeterio; Molly E Ogle; Edward A Botchwey; Nick J Willett; Young C Jang
Journal:  Tissue Eng Part C Methods       Date:  2019-02       Impact factor: 3.056

10.  A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

Authors:  Matthew T Wolf; Sudipto Ganguly; Tony L Wang; Christopher W Anderson; Kaitlyn Sadtler; Radhika Narain; Christopher Cherry; Alexis J Parrillo; Benjamin V Park; Guannan Wang; Fan Pan; Saraswati Sukumar; Drew M Pardoll; Jennifer H Elisseeff
Journal:  Sci Transl Med       Date:  2019-01-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.